24913-62-0Relevant academic research and scientific papers
New phenylalanine derivatives
-
, (2008/06/13)
Specific phenylalanine derivatives or pharmaceutically acceptable. salts thereof have an antagonistic effect on the α4 integrins and, therefore, are usable as therapeutic agents or preventive agents for diseases in which α4 integrin-depending adhesion process participates in the pathology, such as inflammatory diseases, rheumatoid arthritis, inflammatory bowel diseases, systemic lupus erythematosus, multiple sclerosis, Sj?gren's syndrome, asthma, psoriasis, allergy, diabetes, cardiovascular diseases, arterial sclerosis, restenosis, tumor proliferation, tumor metastasis and transplantation rejection.
Positively-chargeable charge control agent and toner for developing electrostatic images
-
, (2008/06/13)
Positively-chargeable charge control agent and toner for developing electrostatic images that comprises a coloring agent, a resin for toners, and said positively-chargeable charge control agent. The positively-chargeable charge control agent comprises a metal complex salt or metal complex of an aromatic dicarboxylic acid having at least 1 perfluoroalkyl group, wherein the central atom of the metal complex salt or metal complex is a trivalent metal.
